proteomics

My newest investment: Genalyte — Augmenting Claremont Creek Ventures’ Digital Healthcare Tools Portfolio

By Brad Webb / April 2, 2012 / 0 Comments

I’m excited that we have recently added a new portfolio company Genalyte to the Claremont Creek digital healthcare family. I’ll be joining the Board, and I am looking forward to working with founder and CEO Cary Gunn and the Genalyte team. Genalyte is a developer and manufacturer of advanced biomarker detection technology strategically located right […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px

NAT GOLDHABER

Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

READ MORE
Brad_Webb8124 1200px crop

BRAD WEBB

Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

READ MORE
Randy_Hawks7690 -1200px

RANDY HAWKS

Randy Hawks is a co-founder of Claremont Creek Ventures.

READ MORE

Post Categories

Keywords

energy tech energy storage SVASE carried interest early-stage targeted customer segments innovation solar words-of-wisdom private equity M&A smartgrid chromosone screening bioinformatics angel investor government policies Personalized Pharmacology awards gene disorder testing cloud computing healthcare government programs power generation Digital Healthcare stem cell thermoelectric energy conservation bionics exit video market conditions Series B swtching costs cleantech funding corporate venture funding government funding market uncertainty genetic screening IPO renewable energy mentoring startups greentech DOOH

Archives